• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BECTON, DICKINSON & CO. (SPARKS) BD BBL TRYPTICASE SOY AGAR (SOYBEAN-CASEIN DIGEST AGAR); CULTURE MEDIA, NON-SELECTIVE AND NON-DIFFERENTIAL

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BECTON, DICKINSON & CO. (SPARKS) BD BBL TRYPTICASE SOY AGAR (SOYBEAN-CASEIN DIGEST AGAR); CULTURE MEDIA, NON-SELECTIVE AND NON-DIFFERENTIAL Back to Search Results
Model Number 221283
Device Problem Microbial Contamination of Device (2303)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 01/21/2021
Event Type  malfunction  
Manufacturer Narrative
A device evaluation is anticipated, but has not yet begun.Upon completion of the investigation, a supplemental report will be filed.
 
Event Description
It was reported that prior to use with 2 bd bbl¿ trypticase¿ soy agar (soybean-casein digest agar) microbial growth was discovered.The following information was provided by the initial reporter: it was reported that vwr scar reported microbial growth on 2 plates of single wrap.
 
Manufacturer Narrative
The following fields were updated due to additional information: d.10.Device available for eval?: yes.D.10.Returned to manufacturer on: 4/26/2021.H.6.Investigation: during manufacturing of material 221283, media is formulated and sent through a high temperature short time sterilizer to remove bioburden.The petri dishes are subjected to uv radiation to decrease bioburden.The petri dishes are filled in a positive pressure hepa filtered environment.The filled plates are cooled and immediately wrapped into sleeves to decrease the introduction of microbes.Sleeves are then packaged into cartons and then transferred to a refrigerated truck (2 to 8o c) for shipment to the distributor.Bd distributors are provided with the storage guidelines for the shipping and handling of bd media of 2 to 8 degrees c in a dark place.The batch history record for batch 0316748 was satisfactory at time of release and no quality notifications were generated during manufacturing and inspection.The release testing that is performed on this product does include bioburden testing.A sample of plates are incubated at 25 degrees c and at 35 degrees c for approximately 72 hours.All bioburden testing performed on this batch was satisfactory per bd internal procedures.Affected product does not have any sterility claims; the product is tested for bioburden prior to release to ensure that it conforms to product specifications.However, this does not ensure that the end-user will not receive a contaminated plate.The complaint history was reviewed, and no other complaints have been taken on batch 0316748.Retention samples from batch 0316748 were not available for inspection.Twenty plates from batch 0316748 were returned as two unopened sleeves shipped in a box with air bubbles and bubble wrap.Plates were inspected and 2/20 plates had surface bacterial growth.Affected plates were submitted to the id lab and corynebacterium pseudodiphtheriticum was identified.One photo also was received.The photo shows the top of an opened 100pack carton and an unopened sleeve with a colony growing on the top plate, from batch 0316748.This complaint has been confirmed.Root cause could not be determined.
 
Event Description
It was reported that prior to use with 2 bd bbl¿ trypticase¿ soy agar (soybean-casein digest agar) microbial growth was discovered.The following information was provided by the initial reporter: it was reported that vwr scar reported microbial growth on 2 plates of single wrap.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
BD BBL TRYPTICASE SOY AGAR (SOYBEAN-CASEIN DIGEST AGAR)
Type of Device
CULTURE MEDIA, NON-SELECTIVE AND NON-DIFFERENTIAL
Manufacturer (Section D)
BECTON, DICKINSON & CO. (SPARKS)
7 loveton circle
sparks MD 21152
MDR Report Key11780755
MDR Text Key278183722
Report Number1119779-2021-00767
Device Sequence Number1
Product Code JSG
UDI-Device Identifier10382902212833
UDI-Public10382902212833
Combination Product (y/n)N
PMA/PMN Number
NA
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type distributor,other,user facili
Type of Report Initial,Followup
Report Date 06/29/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Other
Device Expiration Date03/10/2021
Device Model Number221283
Device Catalogue Number221283
Device Lot Number0316748
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer04/26/2021
Initial Date Manufacturer Received 04/14/2021
Initial Date FDA Received05/05/2021
Supplement Dates Manufacturer Received06/29/2021
Supplement Dates FDA Received07/09/2021
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
-
-